{"id":"W2096365365","doi":"10.1007/s40261-015-0302-x","title":"Safety Profile and Costs of Related Adverse Events of Trastuzumab Emtansine for the Treatment of HER2-Positive Locally Advanced or Metastatic Breast Cancer Compared to Capecitabine Plus Lapatinib from the Perspective of the Canadian Health-Care System","year":2015,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada); Santé Montérégie; Thornhill Medical (Canada)","funders":"","keywords":"Lapatinib; Medicine; Trastuzumab emtansine; Capecitabine; Trastuzumab; Adverse effect; Oncology; Internal medicine; Breast cancer; Clinical trial; Metastatic breast cancer; Taxane; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009043886,0.0001607041,0.0007370588,0.00005070774,0.0001139132,0.000002513759,0.0001815857,0.00006723501,0.00001687316],"category_scores_gemma":[0.00115403,0.0000808318,0.0001301046,0.0004313721,0.0006793708,0.00003972371,0.00003106932,0.0001696326,7.491191e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002736595,"about_ca_system_score_gemma":0.006460079,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.259359,"about_ca_topic_score_gemma":0.3551129,"domain_scores_codex":[0.9972156,0.0006730088,0.001105226,0.0002921779,0.0005017418,0.0002122748],"domain_scores_gemma":[0.9950809,0.001850305,0.0006153748,0.0004322417,0.001653484,0.0003676494],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"qualitative","study_design_gemma":"observational","study_design_scores_codex":[0.06871605,0.002835643,0.2547778,0.004407006,0.007376547,0.00002510167,0.5005025,0.02076925,0.001480885,0.004603765,0.006764259,0.1277412],"study_design_scores_gemma":[0.02297993,0.005744285,0.8288422,0.007752319,0.001012818,0.00001230542,0.115759,0.01361684,0.003639916,0.0001734435,0.0002336258,0.0002333649],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9663683,0.00147348,0.00007485132,0.01846394,0.0002454227,0.007149821,0.006137826,0.000009356395,0.00007706937],"genre_scores_gemma":[0.9982197,0.0001202889,0.0009426129,0.0002302806,0.00004949294,0.000226365,0.0001330481,0.00002228934,0.00005597847],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5740644,"threshold_uncertainty_score":0.9991724,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08230834484887428,"score_gpt":0.4112497931627099,"score_spread":0.3289414483138356,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}